Session Three: Data, digital technologies and real-world evidence
Session Chair: Kathy Williams, Head of Global Regulatory Policy and Intelligence, AstraZeneca, and Vice-Chair,BIA Regulatory Affairs Advisory Committee
Speakers
Kathy Williams
Executive Director Regulatory Policy, Intelligence & Regional Strategy, AstraZeneca
